The  has received renewed funding from the American Cancer Society (ACS) to support a long-standing faculty research program.

The ACS鈥 Institutional Research Grant (IRG) is intended to help junior faculty establish and advance cancer research programs. The grant provides seed money to new investigators to initiate research projects and obtain preliminary results that help them build their programs and successfully compete for extramural funding.

The $360,000 grant will support a total of nine $40K pilot awards over the three-year funding period, which begins in January 2023.

The award is a renewal of the UK Markey Cancer Center鈥檚 IRG, which has been continuously funded since 1985.

鈥淭he ACS IRG has helped several UK faculty members advance their research programs over the past few decades,鈥 said IRG principal investigator Kathleen O鈥機onnor, PhD, a professor in the UK 91小黄车鈥檚 Department of Molecular and Cellular Biochemistry and associate director of cancer education and mentoring at UK Markey Cancer Center.

鈥淭he success of our previous ACS IRG awardees in obtaining extramural funding is a testament to the value this program has to advance cancer research,鈥 O鈥機onnor said. 鈥淭he IRG program has helped to launch impactful research across a number of disciplines required to make progress against cancer including prevention, drug development, biology of cancer cells and health disparities.鈥

With the IRG funds, Markey will continue to host internal grant competitions for faculty. Three pilot awards will be granted each year for the next three years, with the next cycle opening for applications in early 2023.

Grant applications are reviewed by a panel of UK faculty with expertise in all areas of cancer research. The process will select grants with the highest scientific merit and greatest likelihood of obtaining extramural funding.

Markey鈥檚 IRG renewal was  in October, when they approved funding for 89 new Extramural Discovery Science research grants totaling $54.3 million.

The ACS IRG also allows Markey to compete for a Diversity in Cancer Research internship program grant, which has supported the  over the past two years.